<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30384580</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2005-9256</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>Cancer research and treatment : official journal of Korean Cancer Association</Title>                <ISOAbbreviation>Cancer Res Treat</ISOAbbreviation>            </Journal>            <ArticleTitle>Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418).</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.4143/crt.2018.424</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">We compared the oncologic outcomes of breast-conserving surgery plus radiation therapy (BCS+RT) and modified radical mastectomy (MRM) under anthracycline plus taxane-based (AT) regimens and investigate the role of adjuvant radiation therapy (RT) in patients with pathologic N1 (pN1) breast cancer treated by mastectomy.</AbstractText>                <AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">We retrospectively reviewed the medical records of 2,011 patients with pN1 breast cancer who underwent BCS+RT or MRM alone at 12 institutions between January 2006 and December 2010. Two-to-one propensity score matching was performed for balances in variables between the groups.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The median follow-up duration for the total cohort was 69 months (range 1 to 114 months). After propensity score matching, 1,074 patients (676 in the BCS+RT group and 398 in the MRM-alone group) were analyzed finally. The overall survival, disease-free survival, locoregional failure-free survival, and regional failure-free survival (RFFS) curves of the BCS+RT group vs. MRM-alone group were not significantly different. The subgroup analysis revealed that in the group with both lymphovascular invasion (LVI) and histologic grade (HG) III, the BCS+RT showed significantly superior RFFS (p=0.008). Lymphedema (p=0.007) and radiation pneumonitis (p=0.031) occurred more frequently in the BCS+RT group than in the MRM-alone group, significantly.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">There are no differences in oncologic outcomes between BCS+RT and MRM-alone groups under the AT chemotherapy regimens for pN1 breast cancer. However, BCS+RT group showed superior RFFS to MRM-alone group in the patients with LVI and HG III. Adjuvant RT might be considered for pN1 breast cancer patients with LVI and HG III.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yoo</LastName>                    <ForeName>Gyu Sang</ForeName>                    <Initials>GS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Park</LastName>                    <ForeName>Won</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yu</LastName>                    <ForeName>Jeong Il</ForeName>                    <Initials>JI</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Choi</LastName>                    <ForeName>Doo Ho</ForeName>                    <Initials>DH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Yeon-Joo</ForeName>                    <Initials>YJ</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shin</LastName>                    <ForeName>Kyung Hwan</ForeName>                    <Initials>KH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wee</LastName>                    <ForeName>Chan Woo</ForeName>                    <Initials>CW</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Kyubo</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Park</LastName>                    <ForeName>Kyung Ran</ForeName>                    <Initials>KR</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Kosin University Gospel Hospital, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Yong Bae</ForeName>                    <Initials>YB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ahn</LastName>                    <ForeName>Sung Ja</ForeName>                    <Initials>SJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Jong Hoon</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Jin Hee</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chun</LastName>                    <ForeName>Mison</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Hyung-Sik</ForeName>                    <Initials>HS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Dong-A University Hospital, Dong-A University School of Medicine, Busan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Jung Soo</ForeName>                    <Initials>JS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Chonbuk National University Medical School, Jeonju, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cha</LastName>                    <ForeName>Jihye</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Wonju Severance Christian Hospital, Wonju, Korea.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>01</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>Cancer Res Treat</MedlineTA>            <NlmUniqueID>101155137</NlmUniqueID>            <ISSNLinking>1598-2998</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Anthracyclines</Keyword>            <Keyword MajorTopicYN="N">Breast conserving surgery</Keyword>            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Mastectomy</Keyword>            <Keyword MajorTopicYN="N">Pathologic N1</Keyword>            <Keyword MajorTopicYN="N">Radiation Radiotherapy</Keyword>            <Keyword MajorTopicYN="N">Taxane</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30384580</ArticleId>            <ArticleId IdType="pii">crt.2018.424</ArticleId>            <ArticleId IdType="doi">10.4143/crt.2018.424</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>